STOCK TITAN

DaVita (DVA) director Pamela Arway receives 332-share equity award

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Arway Pamela M reported acquisition or exercise transactions in this Form 4 filing.

DaVita Inc. director Pamela M. Arway received an equity award of 332 shares of common stock, recorded at a grant price of $0.00 per share, as non-cash compensation. Following this grant, she directly owns 26,695 shares of DaVita common stock.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Arway Pamela M

(Last) (First) (Middle)
C/O DAVITA INC.
2000 16TH STREET

(Street)
DENVER CO 80202

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
DAVITA INC. [ DVA ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
03/15/2026
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 03/15/2026 A 332 A $0 26,695 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
Remarks:
/s/ Stephanie N. Berberich, Attorney-in-Fact 03/17/2026
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did DaVita (DVA) director Pamela M. Arway report on this Form 4?

Pamela M. Arway reported receiving an equity grant of 332 shares of DaVita common stock. The award was recorded at $0.00 per share, indicating non-cash compensation, and increased her directly held position to 26,695 shares after the transaction.

Was the DaVita (DVA) Form 4 transaction a stock purchase or a grant?

The Form 4 shows a grant or award acquisition, not an open-market stock purchase. Code “A” and a price of $0.00 per share indicate these 332 shares were received as compensation, increasing Pamela M. Arway’s direct holdings to 26,695 shares.

How many DaVita (DVA) shares does Pamela M. Arway own after this Form 4?

After receiving the 332-share equity award, Pamela M. Arway directly owns 26,695 shares of DaVita common stock. This figure reflects her position immediately following the reported non-derivative grant transaction disclosed in the Form 4 filing.

What transaction code is used in this DaVita (DVA) Form 4 and what does it mean?

The filing uses transaction code “A,” which indicates a grant, award, or other acquisition of shares. In this case, Pamela M. Arway received 332 DaVita common shares as non-cash compensation at a recorded price of $0.00 per share.

Does the DaVita (DVA) Form 4 show any stock sales by Pamela M. Arway?

The Form 4 does not report any stock sales. It only shows an acquisition coded as a grant of 332 DaVita common shares at $0.00 per share, increasing her directly held position to 26,695 shares after the transaction.
Davita Inc

NYSE:DVA

View DVA Stock Overview

DVA Rankings

DVA Latest News

DVA Latest SEC Filings

DVA Stock Data

9.91B
33.19M
Medical Care Facilities
Services-misc Health & Allied Services, Nec
Link
United States
DENVER